Several assays can be used to detect MRD in HCL patients; however, while IHC analysis of BM specimens used to be more popular, more recent guidelines recommend the use of MFC and PCR methods for detecting the mutant BRAF V600E gene or consensus primers for IGH (26, 44, 60). The gene discussed is BRAF; the disease is hairy cell leukemia.